argenx SE | ARGX - Ativo Circulante





Ativo Circulante Alterar Data
AstraZeneca USD 27.97B 1.65B 2026-06
Genmab DKK 2.88B 1.59B 2025-12
GlaxoSmithKline GBP 17.56B 202M 2026-06
GRIFOLS EUR 5.25B 180M 2026-03
Hikma Pharmaceutical USD 2.64B 86M 2025-12
Lakefront Biotherapeutics EUR 3.06B 18.72M 2026-03
Qiagen NV USD 1.54B 454.82M 2026-03
UCB EUR 6.05B 733M 2025-12